Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA priority review
Fierce Biotech
Senate hearing takes aim at FDA's rare disease review process
“The members of the panel were like talking to a brick wall,” Jeremy Schmahmann, M.D., testified about his experience at three FDA panels.
Gabrielle Masson
Feb 26, 2026 3:50pm
FDA’s rare pediatric voucher program revived by funding bill
Feb 4, 2026 3:12pm
FDA 'proactively' awards J&J a national priority review voucher
Dec 15, 2025 12:33pm
House vote moves FDA's rare PRV program a step closer to revival
Dec 2, 2025 11:22am
Fierce Biotech
2 lawmakers push for answers as questions swirl over FDA program
Nov 25, 2025 10:30am
Bavarian Nordic's $160M PRV price reflects new realities
Jun 18, 2025 11:47am
